sensitivity of an individual as compared to the visual sensitivity of a normal age-matched control.
In these plots, bright-colors (yellow/white) represent locations in the visual field that are either as sensitive or better than a normal age-matched control, whereas dark-colors (red/maroon) represent location in the visual field with decreased sensitivity from a normal age-matched control. As expected, all HCs demonstrate normal or near normal visual sensitivity across the tested visual field. In each HC, the majority of the SAP maps are bright, which demonstrates similar sensitivity to a normal age-matched control. In contrast, the dramatic reduction in peripheral sensitivity is clearly evident for CHM participants (P2-P4), with dark-colored cells (poor visual sensitivity) in the periphery. For example, P4 who was at a late disease stage exhibits only moderately bright cells at the very center of the visual field for both the left and right eyes. P1, who represents early stages of disease progression exhibits relatively normal visual field sensitivity, particularly for the left eye. In the right eye, the fair right visual field has poorer sensitivity.
Supplementary Figure 1.
Total deviation SAP maps for each CHM participant, HC and eye, respectively. Total deviation maps represent the level of visual sensitivity relative to a normal age-matched control. In these plots, bright-cells (yellow/white) represent locations in the visual field with sensitivity either equal or greater than normal age-matched controls, whereas darkcolors (red/maroon) represent locations in the visual field with decreased sensitivity relative to a normal age-matched control. The black-line on the color-bar represents the same sensitivity as a normal age-matched control. Thus, bright yellow/white cells indicate increased sensitivity and orange/red/maroon cells indicate decreased sensitivity.
Supplementary Figure 2.
Right eye pRF visual field coverage plots for four CHM participants and one healthy control (HC1). Similar to the left eye, assessment of the visual fields was restricted to + 10 and -10 degrees of the entire visual field. The pRF distribution for a typical healthy control (HC1) is presented in the center image. As expected, similar to the left eye, HC1 presented with high pRF values across the visual field with relatively high intensity levels except at the extreme upper and lower vertical meridians, a pattern regularly observed in pRF mapping.
Coverage plots for CHM participants' right eye were assessed relative to HC1's maximum pRF intensity levels. pRF distribution for the CHM participant with most vision (P1) showed similarity to HC1 with higher intensities in the upper left visual field but great reduction of visual intensities in the lower left quadrant. The CHM participant with more advanced disease and limited visual field (P4) showed small centrally located pRF distribution with moderate intensity values. The two CHM participants in mid disease stages (P2 and P3) both showed dramatically more attenuated visual intensities for their right eye pRF distributions as compared to HC1. At the same token, their pRF distributions also differed dramatically from each other. While P2 presented with increase central and right peripheral visual field, P3's visual field coverage was mainly limited to a strong central representation, which was largely restricted to the upper visual field.
Quantification of Relationship Between SAP and pRF Measurements
To quantify the relationship between SAP measurements and pRF parameters, visual field coverage maps needed to be resampled to match the spatial sampling of SAP measurements. 
Quantification of Relationship Between Clinical and pRF Horizontal Eccentricity Profiles
To show the high predictability of the pRF measures for CHM participants' eccentricity profiles, the visual field coverage maps needed to be converted to represent a similar spatial distribution as the clinically measured eccentricity profiles (Supplementary Figure 5) . In accordance with the clinical assessment of eccentricity, pRF maps were restricted to include only the first 4 degrees of visual angle in the vertical dimension ( 2 degrees superior and inferior to the horizontal meridian) across the entire width of the visual field (± 10 degrees eccentricity) (Supplementary Figure 5A , 5B). This restricted field of view was then divided into 11 vertical vectors spanning evenly the entire width of the resampled visual field, to match the spatial sampling of clinical eccentricity assessments. The average pRF value in each vertical vector was then calculated and plotted as a function of horizontal location (Supplementary Figure 5D) . 
Eccentricity Measurements Across the Cortical Surface
Although the majority of analyses were conducted on the significantly modulated voxels pooled across both hemispheres, it is also noteworthy to demonstrate the distribution of pRF eccentricity across the cortical surface. The cortical representation of eccentricity, derived from the right eye pRF scans, are shown on surface reconstructions of both left and right hemispheres for a representative HC (HC1), and two CHM patients at their early and late disease stages respectively (P1 and P4), (see Supplementary Figure 6 ). As expected, the cortical distribution of eccentricity in HC1 follows a well described and predictable pattern 16 It is also worth noting that although CHM participants and controls performed a task at the fixation point, they were not performing a task on the stimulus explicitly. A number of previous studies have investigated the effect of stimulus task on fMRI signals in visual cortex of patients with retinitis pigmentosa 28 and macular degeneration 42 , respectively. It is possible that performing a task on the stimulus 43 may alter the patterns of activity in the periphery of participants with CHM and future studies could explore this possibility.
Reliability of pRF estimates
Unfortunately, in the current CHM and HC groups only a single ~3-minute pRF run was acquired for each eye separately, which makes quantification of pRF reliability difficult. Ideally multiple runs for each eye would be acquired in order to demonstrate the reliability and robustness of the pRF estimates that this model derives. However, previous work 31 employing the exact computational model used here, has reported the reliability of the pRF estimates across independent sets of data in healthy participants. This report, demonstrates high degree of reliability (0.68 < r < 0.94) across the three main parameters of interest and provides reasonable confidence with respect to the pRF measurements acquired in the current experiment.
